Stryker Corporation (SYK) earnings on July 30, 2026
More Stryker Corporation earnings
Prior outlook: No statistical edge
Stryker's stock fell 5.19% after analysts cut their price targets. The drop was part of a negative market reaction to the news.
SYK price around the earnings
325.70
Change: -5.7%
2026-07-31, 20:00 UTC
- Price: green if it ends above the starting price; red if it ends below
- Start of the measured window
- End of the measured window
- Market open
- No trading (market closed)
- Starting price
Prior thesis
Prior outlook: No statistical edge
- Thesis published
- Results released
The recent trend has been strong and analysts cite upside, offset by recent EPS miss and extreme retail optimistic crowding into event.
Context analyzed before publication
- Trend
- Strong run-up from -15.9 to +47.5 into earnings; after a strong recent rise the trajectory suggests expectations fully priced.
Analysts
Evidence
- Analyst consensus
- Buy
- Consensus average (1-5)
- 1.63
- Analysts covering the stock
- 26
- Average price target
- 387.04
- Lowest price target
- 315
- Highest price target
- 465
- Upside to price target
- 11.8%
- Quarterly earnings growth
- 13.9%
- Revenue growth
- 2.6%
- Forward EPS
- 16.73
- Trailing EPS
- 8.63
- Analyst moves in the last 60 days
- 3
- Strong buy: 7
- Buy: 16
- Hold: 5
- Sell: 0
- Strong sell: 0
- Strong buy
- 7
- Buy
- 16
- Hold
- 5
- Sell
- 0
- Strong sell
- 0
- July 9, 2026 · BMO Capital: Initiates coverage (Market Perform → Outperform)
- July 6, 2026 · Evercore ISI Group: Maintains rating (Outperform → Outperform)
- June 5, 2026 · Leerink Partners: Maintains rating (Outperform → Outperform)
News and sentiment
Evidence
Sentiment
- Sentiment
- Constructive
- Mention volume
- Low
- Normalized volume
- 33%
News
Sources (4)
- Here’s How Much You Would Have Made Owning Stryker Stock In The Last 20 Years (opens in a new tab) — Benzinga
- BMO Capital Initiates Coverage On Stryker with Outperform Rating, Announces Price Target of $369 (opens in a new tab) — Benzinga
- Evercore ISI Group Maintains Outperform on Stryker, Lowers Price Target to $350 (opens in a new tab) — Benzinga
- If You Invested $1000 In Stryker Stock 20 Years Ago, You Would Have This Much Today (opens in a new tab) — Benzinga
Technicals
Evidence
- Price when the context was analyzed
- 352.3
- Average true range (ATR)
- 2.9%
- Distance to 52-week high
- -12.6%
- 14-day change (14d)
- +11.4%
- 30-day change (30d)
- +6.6%
- 30-day relative strength
- +8.1%
- SPY change (30d)
- -1.5%
- Nearest support
- 351.35
- Distance to nearest support
- 0.3%
- Nearest resistance
- 353.35
- Distance to nearest resistance
- 0.3%
- Volume accumulation ratio (14d / 46d)
- 0.7
- Major: 351.35 (0.3% away, 0.09 ATR, 43 touches)
- Major: 349.1 (0.9% away, 0.31 ATR, 23 touches)
- Minor: 346.83 (1.6% away, 0.53 ATR, 9 touches)
- Major: 353.35 (0.3% away, 0.1 ATR, 50 touches)
- Major: 355.77 (1% away, 0.33 ATR, 53 touches)
- Major: 358.02 (1.6% away, 0.55 ATR, 63 touches)
Trends
Evidence
- Average earnings surprise
- -1.8%
- April 30, 2026: actual EPS 2.6 vs estimate 2.98 (surprise -12.9%)
- January 29, 2026: actual EPS 4.47 vs estimate 4.4 (surprise +1.7%)
- October 30, 2025: actual EPS 3.19 vs estimate 3.13 (surprise +1.9%)
- July 31, 2025: actual EPS 3.13 vs estimate 3.07 (surprise +1.9%)
Expected move
- Implied move
- +2.0%
- Source
- Options chain
Reactions over its last 20 earnings
- Median move
- 2.7%
- 75th percentile move
- 4%
- 90th percentile move
- 5.8%
- Up / down moves
- 9 / 11
- Average up move
- +3.4%
- Average down move
- -2.7%
Monitoring and close
What Stryker Corporation reported
- Status
- Finished
| Actual EPS | 5.75 |
|---|---|
| EPS estimate | 3.49 |
| EPS surprise | +64.8% |
| Revenue | $6,589 million |
| Revenue estimate | $6,579 million |
| Revenue surprise | +0.2% |
Stryker beat Q2 earnings and sales estimates, but shares fell after hours on cyberattack concerns and cautious guidance, despite raising FY2026 EPS outlook.
Sources (10)
- Stryker (SYK) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates (opens in a new tab) — Zacks
- Stryker (SYK) Q2 Earnings and Revenues Beat Estimates (opens in a new tab) — Zacks
- Stryker (NYSE:SYK) Slips After Q2 Revenue Miss Overshadows Earnings Beat (opens in a new tab) — ChartMill
- Stryker Logs Higher Profit, Revenue Amid Cyberattack Recovery (opens in a new tab) — The Wall Street Journal
- Stryker (NYSE:SYK) Posts Q2 CY2026 Sales In Line With Estimates But Stock Drops (opens in a new tab) — StockStory
- Stryker Raises FY2026 Adj EPS Guidance from $14.90-$15.10 to $14.95-$15.10 vs $14.97 Est (opens in a new tab) — Benzinga
- Correction: Stryker Q2 Adj. EPS $3.69 Beats $3.49 Estimate, Sales $6.589B Beat $6.579B Estimate (opens in a new tab) — Benzinga
- Stryker reported adjusted earnings of $5.75 per share, beating the $3.49 estimate, and sales of $6.589B, above the $6.579B expected. — Benzinga
- Stryker Q2 Adj. EPS $5.75 Beats $3.49 Estimate, Sales $6.589B Beat $6.579B Estimate (opens in a new tab) — Benzinga
- Stryker reports second quarter 2026 operating results (opens in a new tab) — Yahoo
Pre-market second reading after the results
- Verdict
- Beat expectations
Heading into the open, results beat expectations on both earnings and revenue, and the price is indicating -6.7% pre-market, a move above the stock's usual reaction (about 3%). The figures don't confirm the prior scenario: there was no prior directional scenario to check against.
How the stock reacted
- Consolidated
- -5.2%
- Max move
- -11.1%
No verdict: the outlook took no direction, so there is nothing to score as a hit or a miss.